Recent experimental evidence suggests that environmental microbial factors early in life determine susceptibility to allergic diseases through inappropriate chemotaxis and local activation of CD1d-restricted, invariant chain natural killer T (iNKT) cells. In this study, we analyzed the involvement of these pathways in pediatric patients with eosinophilic esophagitis (EoE) before and after dietary allergen elimination.
INTRODUCTION
A wide variety of allergic and immune-mediated infl ammatory disorders are rapidly and globally increasing ( 1, 2 ) , suggesting that environmental factors are critical mediators of these changes ( 3 ). Moreover, the increasing incidence of these diseases is especially apparent among children ( 4 -6 ) , which implicates a role for the environment in the processes of education and development of the immune system that follow the acquisition of a commensal microbiota along mucosal surfaces early in life ( 7, 8 ) .
Recently, direct evidence has emerged from animal models of asthma and infl ammatory bowel disease (IBD) that microbially derived signals during a critical neonatal time frame are important regulators of later-life susceptibility to immune-mediated diseases ( 9 ) . Furthermore, environmentally induced disruptions of these signals, such as those that result from the use of antibiotics, conferred increased susceptibility to experimental asthma and IBD ( 9, 10 ) . Th ese rodent models have focused particular attention on the role played by microbial-induced expression of chemoattractant chemokines that promote infi ltration of mucosal tissues with invariant natural killer T (iNKT) cells. iNKT cells respond to host and microbial lipid antigens when presented by CD1d and rapidly express a variety of mediators that Involvement of the iNKT Cell Pathway Is Associated With Early-Onset Eosinophilic Esophagitis and Response to Allergen Avoidance Therapy regulate downstream immune events and eff ector cells ( 11, 12 ) . In the absence of microbiota during neonatal, but not adult life, as in germ-free or antibiotic-treated mice, such tissues express increased quantities of C-X-C motif chemokine ligand 16 (CXCL16), a chemokine involved in iNKT cell traffi cking ( 9, 13 ) . When these early-life microbial signals are not provided, an excessive and persistent accumulation of iNKT cells occurs in the colon and lungs. Consequently, these mucosal tissues are rendered more susceptible to later-life environmental triggers of iNKT cells, which are potent and rapid producers of T helper type 2 (Th 2)-type cytokines such as interleukin (IL)-4, IL-5, and IL-13, which mediate allergic sensitization and tissue infl ammation ( 9, 12, 14 ) . Th ese model studies suggest that microbially regulated immune events during early life, or lack thereof as a consequence of, for example, antibiotic administration, are critical determinants of later-life susceptibility to allergic disease. In addition, given that components of CD1d-restricted T-cell pathways and their regulating factors such as CXCL16 serve as mediators of this susceptibility, it is reasonable to expect that they have a potential role as markers for disease risk in humans.
To test the relevance of the hypothesis that early-life events determine the tone of CD1d-restricted T-cell pathways and susceptibility to immune-mediated diseases in humans, we turned our attention to pediatric patients with eosinophilic esophagitis (EoE). EoE is characterized by chronic eosinophilic infl ammation of the esophagus and is strongly associated with allergies to inhaled and food-derived antigens ( 15, 16 ) . Like other allergic diseases, the disorder oft en manifests during childhood ( 17 ) and is undergoing a rapid increase in incidence and prevalence worldwide ( 6, 18, 19 ) , suggesting a pathogenic role of yet-to-be defi ned environmental factors ( 16 ) .
In addition to their previously established role in asthma and IBD ( 20, 21 ) , iNKT cells have recently been implicated in the pathogenesis of experimental EoE ( 22 ) . To study the involvement of this pathway in EoE, here we analyzed the mRNA expression levels of CXCL16, as well as iNKT cells and their markers, in serum and esophageal biopsies that were obtained before and aft er treatment with an allergen-elimination diet.
METHODS

Study population
Th e patients included in this study are part of an observational longitudinal cohort study at Boston Children ' s Hospital that aims at understanding the pathophysiology of EoE and is approved by the institutional Investigational Review Board (Harvard Medical School, Boston, MA) ( 23 -25 ) . Parents of children aged 0 -18 years whose clinical presentation indicated possible EoE (e.g., feeding intolerance, food aversion, dysphagia, failure to thrive) were invited to participate. Before routine diagnostic endoscopy, caregivers were asked to fi ll out a questionnaire regarding the child ' s past medical history, current and past symptomatology, allergic comorbidity, and dietary habits. We only considered children to be food allergic when foods were avoided based on the results of RAST (radioallergosorbent test), skin prick, or patch testing. Upon written informed consent, serum and additional esophageal biopsies were obtained. EoE was diagnosed according to the current consensus guidelines ( 26 ) . Aft er diagnosis, patients were treated independently of this study but were again asked to participate when admitted for follow-up endoscopy. Since 2008, 451 children have been included in the cohort, 160 of whom received a diagnosis of EoE. Th e 291 non-EoE patients had either normal esophageal tissue biopsies ( N = 225) or infl ammation that was classifi ed by the hospital pathologist as consistent with refl ux esophagitis ( N = 66). Within this patient cohort, we focused on 31 biopsies available from patients aged < 6 years (18 EoE, 5 refl ux esophagitis, and 8 normal histology) as well as 16 biopsies from patients aged ≥ 6 years old (10 EoE, 6 normal histology). Twelve follow-up biopsies from EoE patients aged < 6 years were available for analysis.
Sample preparation and assay
Study biopsies from the distal esophagus (approximately 2 cm from the gastro-esophageal junction) were collected in RNA later (Qiagen, Valencia, CA) and stored at − 80 ° C before processing. Tissue was homogenized in 350 μ l RLT Buff er (Qiagen) with β -mercaptoethanol (Sigma, St Louis, MO) in GentleMACS M tubes (Miltenyi Biotec, Auburn, CA), and RNA was extracted using the RNeasy plus kit (Qiagen). RT-qPCR (quantitative reverse transcriptase -PCR) was performed using Taqman gene expression assays (Applied Biosystems, Foster City, CA) for CXCL16, CD1d, CD1a, C-X-C motif chemokine receptor 6 (CXCR6), TRAV10 (V α 24), CD3 ε , leukotriene C 4 synthase (LTC 4 S), eotaxin-3, and periostin in duplex RT-qPCR reactions with the housekeeping gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase; C1000 Th ermal Cycler, Bio-Rad, Herculus, CA). Gene expression relative to GAPDH ( Δ Δ ) was calculated. Pooled cDNA from fi ve control patients was used as an inter-run calibrator. CXCL16 protein levels were measured in serum using a commercially available enzyme-linked immunosorbent assay according to the manufacturer ' s instructions (R & D Systems, Minneapolis, MN). 
Statistical analysis
RESULTS
The CXCL16 -iNKT -CD1d axis is prominently involved in early-onset EoE patients
To investigate the contribution of CXCL16 to local disease in EoE, we analyzed mRNA expression levels of CXCL16 in esophageal biopsies at the time of diagnosis in 47 children. Patients were grouped according to age at diagnosis: (i) patients aged < 6 years (18 EoE vs. 13 non-EoE, of whom 5 with histological evidence of refl ux esophagitis) and (ii) 6 -18 years (10 EoE vs. 6 non-EoE with normal tissue histology). CXCL16 was expressed in all esophageal biopsies analyzed (cycle threshold range 26.6 -32.7), but expression was signifi cantly higher in EoE patients when compared with controls (3.2 ± 0.3 vs. 1.2 ± 0.2, P < 0.001, Figure 1a ). Furthermore, expression levels were higher in early-onset EoE patients, which we defi ned as children diagnosed < 6 years of age, compared with their older EoE counterparts (3.7 ± 0.4 vs. 2.2 ± 0.2, P < 0.05). No age-dependent diff erence was seen in the non-EoE control patients (1.3 ± 0.3 vs. 1.0 ± 0.1, P = 0.52, Figure 1a ) .
We analyzed the same biopsies for mRNA expression of CXCR6, the canonical receptor for CXCL16 that is expressed on a variety of T-cell subsets, including Th 1-polarized CD4 + and CD8 + T cells ( 27 ) , as well as iNKT cells ( 28 ) . Although higher expression levels were seen in EoE patients compared with non-EoE controls ( Figure 1b ) , the highest expression levels were observed in EoE patients aged 6 -18 years. In light of the elevated CXCL16 levels observed in EoE patients < 6 years old, these results are consistent with observations that CXCR6 in T cells is downregulated upon activation ( 29 ) and suggest that CXCL16 engagement is highly active in early-onset EoE patients.
To determine whether CXCL16 overexpression was indeed associated with infi ltration of iNKT cells, we analyzed gene expression of V α 24, an essential component of the invariant T-cell antigen receptor (TCR) of iNKT cells ( 30 ) . V α 24 TCR mRNA transcripts were detected in 17 of the 18 early-onset EoE patients, all 10 older EoE patients, and in 14 of the 19 control patients. In line with CXCL16 expression results, the highest levels of V α 24 TCR mRNA were detected in EoE patients aged < 6 years ( Figure 1c ). Increased V α 24 expression did not result from more pronounced overall T-cell infi ltration, because expression levels of the ε chain of the TCR (CD3 ε ) were equivalent in both young and older EoE patients ( Figure 1d ), and normalization of V α 24 expression against CD3 ε or CXCR6 did not resolve the diff erence between old and young EoE patients ( Figure 1e ). Th ese results suggest the existence of distinct diff erences in infi ltrating T-cell subsets between early-onset and older EoE patients.
iNKT cells are restricted by recognition of lipid antigen presented through CD1d on antigen-presenting cells ( 12 ) . We therefore examined CD1d mRNA and observed increased expression in EoE patients compared with non-EoE control patients, indicating that at the site of infl ammation there is an enhanced capacity to activate infi ltrating iNKT cells ( Figure 1f ). Indeed, we depicted a positive correlation between tissue mRNA expression of CD1d and V α 24 in esophageal biopsies (Spearman ρ = 0.654, P < 0.001, Figure 1g ). Similarly, expression of CXCL16 and V α 24 correlated positively (Spearman ρ = 0.542, P < 0.001, Figure 1g ).
Conversely, expression levels of CD1a, a related glycoprotein on antigen-presenting cells, did not diff er between EoE patients and controls (1.0 ± 0.2 vs. 1.2 ± 0.2, P = 0.38), arguing that increased CD1d expression in EoE is part of the disease-specifi c immune phenotype rather than the result of overall increase in tissue myeloid or infl ammatory cells ( Figure 1h ). Combined, these data show local involvement of the CXCL16 -iNKT -CD1d axis in EoE patients and that this involvement is signifi cantly more prominent in early-onset EoE patients.
Serum CXCL16 levels in early-onset EoE patients are consistent with an age-dependent role in EoE pathogenesis
CXCL16 is present as a membrane-bound protein on epithelial and myeloid cells, as well as a soluble form, that can be retrieved from patient serum ( 31 ) . We hypothesized that early-onset EoE patients might also be characterized by higher levels of CXCL16 in serum when compared with non-EoE control patients, as was observed in tissues ( Figure 1a ). If so, this might serve as a convenient biomarker for disease. Serum levels were similar between the patient groups (2.9 ± 0.2 μ g / ml for EoE ( N = 18) vs. 2.6 ± 0.1 μ g / ml for non-EoE ( N = 24), P = 0.19, Figure 1i ). Interestingly, there was a signifi cant negative correlation between serum CXCL16 levels and age of diagnosis in EoE ( r = − 0.65, P = 0.004, Figure 1j ). Conversely, this relationship between age and serum CXCL16 levels was absent in the non-EoE patients ( r = − 0.16, P = 0.46, Figure 1j ) and EoE patients aged 6 -18 years ( N = 8, r = 0.31, P = 0.45). Th ese results further support an agedependent role for CXCL16 in EoE pathophysiology, which is detectable in the serum.
Involvement of the CXCL16 -iNKT -CD1d axis is associated with a more pronounced food allergic phenotype
As CXCL16 overexpression and iNKT cell infi ltration were significantly more pronounced in the younger EoE patients, we asked whether early-onset EoE diff ers from EoE that becomes apparent during later childhood. Within our entire cohort of 451 patients, 44 of the 160 EoE patients (28 % ) were < 6 years at the time of diagnosis. In line with data from multiple patient populations ( 6, 19 ) , we saw a strong male preponderance in EoE patients, as well as a higher occurrence of all investigated allergic diatheses compared with control patients ( Table 1 ) . Comparison between EoE patients aged < 6 and ≥ 6 years, however, revealed striking differences in the distribution of allergic comorbidity. Whereas older patients were more likely to be asthmatic (50 vs. 20 % , P = 0.003), early-onset EoE patients had signifi cantly more oft en been diagnosed with food allergy against milk (32 vs. 14 % , P = 0.02) or any specifi c food allergen (48 vs. 25 % , P = 0.008) through skin prick, patch, or RAST testing. Th ese epidemiological data are suggestive of a particularly dominant role of food allergic sensitization in early-onset EoE.
To further test this hypothesis at the tissue level, we again turned to tissue biopsies. We have recently demonstrated that elevated mRNA levels of LTC 4 S mark a subpopulation of EoE patients with a more pronounced local allergic phenotype ( 25 ) . No diff erence was found in tissue eosinophil counts between early and later-onset , and non-EoE controls (patients aged < 6 years shown as full squares and patients aged 6 -18 years as open squares) ( a -f , h ). mRNA expression levels were elevated in EoE patients compared with non-EoE controls for CXCL16 ( a ), C-X-C motif chemokine receptor 6 (CXCR6) ( b ), V α 24 T-cell antigen receptor (TCR) ( c ), CD3 ε ( d ), and CD1d ( f ), but not for CD1a ( h ). Early-onset EoE patients express signifi cantly higher levels of CXCL16 ( a ), CXCR6 ( b ), and V α 24 TCR ( c ) when compared with older EoE patients. Ratio of expression is plotted for V α 24 / CD3 ε and V α 24 / CXCR6 ( e ). ( g ) V α 24 TCR mRNA levels correlated signifi cantly with CD1d and CXCL16. Expression values under the detection limit or the corresponding expression ratios are plotted under the dotted line when transcripts were not detected. ( i ) Serum CXCL16 levels of early-onset EoE patients were compared with age-matched non-EoE controls.
( j , k ) Serum CXCL16 was correlated to age at diagnosis. * P < 0.05; * * P < 0.01; * * * P < 0.001; NS, not signifi cant.
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cellular source of IL-13. Th ese data suggest a link between the local expression of CXCL16 and eff ector pathways of EoE at the site of tissue infl ammation.
Treatment with elimination diet leads to normalization of the CXCL16 -iNKT -CD1d axis in early-onset EoE patients
To analyze the response of the CXCL16 -iNKT -CD1d axis to EoE treatment, we repeated mRNA measurements in biopsies that were obtained during follow-up endoscopies performed to monitor disease progression and therapeutic response. Follow-up biopsies were available from 12 of the 18 early-onset EoE patients aft er a median follow-up time of 10.1 months (range 1.9 -24.8 months).
Based on the degree of tissue eosinophilia obtained from routine histopathological analysis, 7 of the 12 EoE patients had significantly improved with treatment, with median eosinophil counts of 8 / high power fi eld (hpf) (range 0 -25) compared with the initial biopsies that showed a median of 100 eosinophils / hpf (range 37 -120, P = 0.02 by Wilcoxon signed rank test, Figure 3a ). Conversely, in the fi ve non-responding patients, tissue eosinophilia at EoE patients ( Figure 2a ). However, in line with our epidemiological data, we found that early-onset EoE patients had signifi cantly higher levels of LTC 4 S mRNA expression ( Figure 2b ). In addition, we analyzed tissue biopsies for EoE marker genes eotaxin-3, periostin, and IL-13, which were among the fi rst genes to be identifi ed as part of an EoE-specifi c esophageal transcriptome ( 32 -34 ) . We observed that all were increased in patients with EoE relative to the non-EoE subjects ( Figures 3c -e ) . Although no age-dependent diff erences in expression were found, we observed a strongly positive correlation between tissue mRNA expression levels of CXCL16 and these marker genes ( Figure  3c -e ) . Eotaxin-3 has been identifi ed as one of the key eosinophil attractant cytokines in EoE ( 32 ), and periostin is described to facilitate eosinophil tissue infi ltration ( 33 ) . Expression of both eff ector molecules has been described to occur downstream of IL-13 signaling in EoE ( 33, 34 ) . Although IL-13 is produced by iNKT cells ( 12 ), we did not observe a signifi cant correlation between expression of IL-13 and V α 24 ( r = 0.13, P = 0.50), indicating that iNKT cells are unlikely to be the dominant 
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follow-up remained high, ranging from 40 to 120 eosinophils / hpf (median 100 / hpf, P = 0.25). In line with tissue eosinophil counts and previously published data ( 34 ), mRNA expression levels of eotaxin-3 and periostin at follow-up had decreased signifi cantly in responding patients, whereas this reduction was smaller and not signifi cant in the non-responders ( Figure 3a ). Patient and treatment details are summarized in Table 2 . We next turned our attention to the CXCL16 -iNKT cell -CD1d axis in treated patients. We observed that, in the seven responders, CXCL16 mRNA expression completely normalized to the expression levels encountered in age-matched control patients (1.2 ± 0.1 vs. 1.3 ± 0.3, P = 0.88, Figure 3b ). In contrast, CXCL16 expression remained signifi cantly elevated in the fi ve non-responders (2.3 ± 0.4) when compared with control patients ( P = 0.01) as well as responding EoE patients ( P = 0.03). CXCR6 and V α 24 TCR mRNA levels also decreased signifi cantly in the seven responding patients (2.7-fold, P = 0.02 and 3.3-fold, P = 0.03, respectively) but not in the non-responders ( P = 1.0 and P = 0.63, Figure 3c ). Likewise, response to treatment was associated with a 17-fold reduction in CD1d expression ( P = 0.01) compared with a 1.5-fold reduction in non-responders ( P = 0.31, Figure 3d ). No decrease, but rather an increase, in CD1a expression levels was observed upon successful treatment (2.0-fold increase, P = 0.03), in this case showing that reduction of CD1d mRNA levels did not result from decreased myeloid cell infi ltration ( Figure 3e ). Finally, we found that LTC 4 S mRNA levels only decreased following successful treatment (4.0-fold, P = 0.03 compared with 1.3-fold, P = 0.81 in non-responders, Figure 3f ). Allergen avoidance therapy did not aff ect the levels of serum CXCL16 ( Figure 3g ), confi rming that upregulation of CXCL16 represents a local mucosal event that is not broadcasted systemically. Together, these data show that involvement of the CXCL16 -iNKT cell -CD1d axis can be modifi ed by dietary interventions that aim to eliminate common allergens from the diet. Figure 2 . C-X-C motif chemokine ligand 16 (CXCL16) correlates with allergic mediators in early-onset eosinophilic esophagitis (EoE). Early-onset EoE patients do not show ( a ) more severe tissue eosinophilia (counts / hpf (high power fi elds)) or increased expression of EoE-specifi c marker genes ( c ) eotaxin-3, ( d ) periostin, or ( e ) interleukin (IL)-13 but show a more pronounced allergic tissue phenotype as signifi ed by increased expression of ( b ) leukotriene C4 synthase (LTC 4 S). In EoE patients, CXCL16 expression correlates with IL-13 and disease-specifi c, IL-13-dependent tissue markers eotaxin-3 ( c ) and periostin ( d ). * * P < 0.01; * * * P < 0.001; NS, not signifi cant.
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EoE is potentially associated with use of antibiotics during the fi rst year of life Animal model experiments suggest that CXCL16 overexpression by epithelial cells can result from inadequate instruction from the commensal microbiota at an early age ( 9 ) . We therefore hypothesized that antibiotic treatment during the fi rst year of life may be associated with the development of EoE, as has been previously suggested for pediatric IBD ( 35 ) and asthma ( 36 ) and, very recently, also for EoE ( 37 ) . Unfortunately, our questionnaires at the time of study enrollment did not directly address the extent of early-life antibiotic exposure or mode of delivery but instead inquired into medication use during the fi rst year of life, in particular the use of antacids, corticosteroids, and prokinetics. Data on the prescription of antibiotics was obtained through an openended question asking parents to list additional medications during the fi rst year of life. Questionnaires of 451 patients (160 EoE) were analyzed. Antibiotics in the fi rst year of life were reported in 29 patients, of whom 20 were subsequently diagnosed with EoE ( P < 0.001). Although it is very likely that under-reporting aff ected the total number of cases, the diff erence between EoE patients 
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( < 6 years), and the elements of the CXCL16 -iNKT cell -CD1d pathway correlated with the presence of infl ammatory mediators associated with EoE-specifi c infl ammation (eotaxin, periostin), pointing towards a direct role in disease pathogenesis. Indeed, successful dietary therapy was associated with the resolution of disease, together with a synchronous and proportionate decrease in the levels of CXCL16, CD1d, and V α 24, suggestive of a causeand-eff ect relationship. Given the observations in animal models, these fi ndings in humans with EoE support the hypothesis that early-life events that aff ect CD1d-restricted T-cell pathways at mucosal surfaces have an important role in the pathogenesis of EoE. Indeed, we detected an association between antibiotic use in the fi rst year of life and the development of EoE, drawing additional and provocative similarities to the aforementioned animal studies. Together, these studies support the concept that a pathway involving environmentally induced changes in early life, in this case caused by antibiotic administration, cause perturbations in mucosal iNKT cell homeostasis in esophageal tissues and determines susceptibility to EoE. Previous translational studies on the role of iNKT cells in human allergy have predominantly been performed in asthmatic patients, aft er it was shown that iNKT cells are required for the induction of experimental airway hyper-reactivity in mice ( 12, 38, 39 ) . As eff orts to demonstrate increased levels of iNKT cells in bronchoalveolar lavage fl uid of asthmatic patients have not yielded clear diff erences with control populations ( 30, 40, 41 ) , such a role has remained a matter of debate ( 21, 42 ) . Th ese analyses of bronchoalveolar lavage fl uid have, however, been performed in adult patients with a longstanding history of asthma and therefore do not rule out a potential role for iNKT cells in the early phase of disease pathogenesis. Th is concept is further supported by recent experimental work that suggests that rather than being the main eff ector cell in advanced asthma, iNKT cells are critically involved in the allergic sensitizaand controls is unlikely the result of recall bias. Th is is because report of non-antibiotic drug-use during the fi rst year of life did not diff er between cohorts (33 % of EoE patients vs. 41 % of nonEoE controls, P = 0.09), and questionnaires were fi lled out before diagnosis. Furthermore, a positive association (odds ratio 4.10, 95 % confi dence interval 1. 36 -12.35) between EoE and reported antibiotics use during the fi rst year of life remained aft er adjustment for sex, age, prematurity, hospitalization in the fi rst year of life, allergic comorbidities, and non-antibiotic drug use in the fi rst year of life ( Table 3 ). Although statistical signifi cance was reached for this association in our cohort, additional epidemiological studies designed to specifi cally address this question are needed to confi rm a causative link between early-life antibiotic exposure and occurrence of EoE later in life.
DISCUSSION
In the current study, we provide evidence that supports the involvement of CD1d-restricted iNKT cell pathways in the pathogenesis of pediatric EoE. Th ere are several key elements associated with the fi ndings contained here. First, our results provide a direct human corollary of previous observations in animal models that commensal microbes, in an age-dependent fashion, regulate iNKT cell accumulation in the colon and lung by altering expression of chemokine ligands that promote iNKT cell migration, such as CXCL16. Similar to this previous report, we found that all of the factors associated with iNKT cells such as the associated TCR chain (V α 24), the antigen-presenting molecule that regulates their activity (CD1d), and the chemokine ligand that determines their chemotaxis into tissues (CXCL16), are observed at signifi cantly higher levels in the esophageal tissue of EoE patients compared with normal or infl ammatory controls. Moreover, the highest levels were observed in children with early-onset EoE 
ESOPHAGUS
Involvement of the iNKT Cell Pathway in EoE
tion phase of disease. Specifi cally, Scanlon et al. ( 14 ) showed that intratracheal exposure to bacterial lipid antigens resulted in rapid peribronchiolar infi ltration of iNKT cells and formation of eosinophil-rich granulomas. Upon intratracheal co-administration of ovalbumin, a Th 2 immune response was mounted against ovalbumin, including synthesis of anti-ovalbumin immunoglobulin E. Allergic sensitization persisted until months aft er the initial exposure and, once established, was independent of iNKT cells ( 14 ) . Th ese observations thus point towards iNKT cells as a crucial instigating cell type in allergic forms of infl ammation and demonstrate that once allergic sensitization has occurred, cytokine production by iNKT cells is dispensable for disease pathogenesis. Th e latter fi nding likely explains the absence of a correlation between IL-13 and V α 24 expression in our cohort. By studying pediatric EoE patients at the time of diagnosis, we were able to obtain aff ected mucosal tissues to directly correlate the involvement of iNKT cells and their mediators with disease phenotype. Like asthma, EoE is a chronic, immune / antigen-driven condition characterized by aberrant Th 2 immune responses and allergic sensitization ( 26 ) . Both food-derived and inhaled allergens have been implicated in its pathogenesis ( 26, 43, 44 ) , which is refl ected in high response rates upon initiation of an elemental or six-food elimination diet ( 45, 46 ) . As a corollary, increased esophageal eosinophilia is observed during the pollen season in pollen-sensitized patients ( 47, 48 ) . A likely role for iNKT cells in the process of allergic sensitization was suggested from studies that showed that food-allergen dependent, experimental murine EoE could not be induced in CD1d-defi cient mice ( 22 ) . Consistent with this, we have shown that individual components of the CXCL16 -CD1d -iNKT axis are overexpressed in our entire pediatric EoE population, but increased expression was signifi cantly more prominent in patients who developed the disease at a very young age. Epidemiological data from our cohort study further indicate that in patients diagnosed when < 6 years of age, EoE is characterized by a higher fraction of food-allergic sensitization. In addition, local mRNA levels of LTC 4 S, the enzyme that generates the allergic mediator leukotriene C4, were signifi cantly higher in children with early-onset EoE than in their older counterparts. As such, these data suggest that this early-onset disease phenotype is likely to depend more heavily on local sensitization to food-derived allergens. Our results are therefore supportive of an association between local accumulation of iNKT cells and allergic sensitization to food antigens in human EoE. Additional support for our concept was provided recently by Jyonouchi et al. , ( 49 ) who reported increased numbers of iNKT cells in esophageal biopsies of pediatric patients with active disease. Upon stimulation with milk-derived sphingolipids, iNKT cells from these EoE patients readily responded with increased IL-13 and IL-4, but not interferon-γ production, showing that iNKT cellmediated responses to food-derived antigens can be responsible for Th 2 skewing of immune responses ( 49 ) .
Despite recent advances in our understanding of iNKT cell biology, the exact molecular mechanism that couples iNKT cell infi ltration to allergic sensitization in human EoE patients remains to be further identifi ed. iNKT cells are CD1d-restricted and can be activated in response to exogenous lipid antigens, including pollen and dust mite -associated lipids ( 50,51 ), as well as dietary antigens such as sphingomyelin derived from milk ( 52 ) or the allergen Ber e1 from Brazil nuts in the presence of a naturally occurring lipid fraction ( 53 ) . Th e study by Olszak et al. ( 9 ) has furthermore implicated endogenous (self) antigens as a source of iNKT stimulation in a pathogenic environmental context and showed that microbes inhibit this auto-reactivity, at least in part, through dampening CXCL16 expression. It is therefore of interest that we identifi ed a relationship between early-life antibiotic use and EoE, suggesting that microbial reduction during early life may also confer risk for the development of EoE as previously demonstrated for asthma ( 36, 54 ) and IBD ( 35 ) in humans. Such antibiotic use may diminish the quantity and / or activity of microorganisms capable of regulating iNKT cells. Interestingly, in this regard is evidence that Bacteroides fragilis encodes a biosynthetic pathway for the generation of glycosphingolipids capable of inhibiting colonic iNKT cells, suggesting that antibiotics which diminish this or similar types of organisms may predispose to iNKT cell-mediated diseases ( 55 ) . Our longitudinal cohort study was not designed to specifi cally address the potential association between antibiotics use and onset of EoE, which has resulted in potential under-reporting of early-life antibiotic use and the absence of data on the quantity or types of antibiotics prescribed. Although our data suggest that the association between early-life antibiotic exposure and development of EoE was not due to recall bias, we caution that additional epidemiological studies are needed to prove this important hypothesis. We propose that EoE is a suitable model disease for such studies, as an association with antibiotic exposure is less susceptible to reverse causation, which has hampered inference from pediatric asthmatic cohorts ( 56 ) . Indeed, gastrointestinal symptoms are less likely to be treated with antibiotics than upper or lower airway infections, and symptomatology was not more pronounced in EoE patients compared with controls in our cohort. Supportive of our data is a recently published paper that has described an association of the same order of magnitude between EoE and antibiotic use during infancy as found in our study ( 37 ) . Large European studies have further pointed out that exposure to a wide variety of environmental microorganisms confers protection against both atopy and asthma ( 7 ), making it reasonable to surmise that similar mechanisms are operative in EoE.
In summary, we have assessed how recent fi ndings from experimental studies in mouse models translate to human allergic disease in the context of EoE. Based on our results, we propose the following model of EoE pathophysiology: (1) Insuffi cient immune imprinting by environmental microorganisms results in esophageal upregulation of CXCL16 and chemotaxis of iNKT cells into the esophagus, making the esophagus susceptible to triggers of iNKT cell activation; (2) Lipid antigens derived from food, aeroallergens, microorganisms, and / or potentially self-antigens associated with the esophagus are inappropriately presented to iNKT cells by CD1d in a manner that stimulates their pathological activation; (3) Activated iNKT cells serve as an early source of IL-4, IL-5, and IL-13, facilitating Th 2-mediated allergic sensitization and responses that promote and sustain infl ammation. Our observations further suggest that in an esophageal iNKT cell -dominant disease phenotype, as occurs early in life, allergic infl ammation is driven primarily by food antigens. Conversely, in EoE that manifests at a later age, esophageal infl ammation is potentially less dependent on iNKT cells based upon our fi ndings. Th is model of disease pathophysiology suggests that pharmacological interference with CXCL16 and CD1d, especially at a young age and at onset of disease, is a potent target in the prevention and treatment of allergic diseases such as EoE and may further serve as diagnostic markers in determining disease etiology and therapeutic response.
